Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics

This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gynecological endocrinology Ročník 36; číslo 6; s. 508 - 512
Hlavní autoři: Jiang, Yihong, Qi, Jia, Xue, Xinli, Huang, Rong, Zheng, Jun, Liu, Wei, Yin, Huiyong, Li, Shengxian
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Taylor & Francis 02.06.2020
Témata:
Adolescent
Adult
Biomarkers - blood
Case-Control Studies
ceramide
Ceramides - blood
Ceramides - classification
China
Cross-Sectional Studies
Female
Humans
insulin resistance
Lipidomics - methods
Lipids - blood
Pilot Projects
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - diagnosis
Predictive Value of Tests
shotgun lipidomics
Up-Regulation
Young Adult
China
Polycystic ovary syndrome
ceramide
shotgun lipidomics
insulin resistance
ISSN:0951-3590, 1473-0766, 1473-0766
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed to analyze serum lipid profiles. Shotgun lipidomics revealed that the concentrations of ceramide (Cer) and phosphatidylcholine (PC) were higher (PC: 831.6 ± 217.4 vs. 605.2 ± 164.2 μmol/l; Cer: 3,387.6 ± 829.9 vs. 2,552.2 ± 679.4 nmol/l, respectively), whereas that of lysophosphatidylcholine was lower, in PCOS women than in healthy controls (82.02 ± 39.49 vs. 133.62 ± 65.36 μmol/l, respectively). Receiver operating characteristic analysis showed that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) had the greatest discriminatory power to differentiate between women with and without PCOS (area under the curve: 0.889, 95% confidence interval: 0.784-0.994). These results indicate that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) may represent a novel lipid predictor of PCOS.
AbstractList This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed to analyze serum lipid profiles. Shotgun lipidomics revealed that the concentrations of ceramide (Cer) and phosphatidylcholine (PC) were higher (PC: 831.6 ± 217.4 vs. 605.2 ± 164.2 μmol/l; Cer: 3,387.6 ± 829.9 vs. 2,552.2 ± 679.4 nmol/l, respectively), whereas that of lysophosphatidylcholine was lower, in PCOS women than in healthy controls (82.02 ± 39.49 vs. 133.62 ± 65.36 μmol/l, respectively). Receiver operating characteristic analysis showed that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) had the greatest discriminatory power to differentiate between women with and without PCOS (area under the curve: 0.889, 95% confidence interval: 0.784-0.994). These results indicate that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) may represent a novel lipid predictor of PCOS.
This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed to analyze serum lipid profiles. Shotgun lipidomics revealed that the concentrations of ceramide (Cer) and phosphatidylcholine (PC) were higher (PC: 831.6 ± 217.4 vs. 605.2 ± 164.2 μmol/l; Cer: 3,387.6 ± 829.9 vs. 2,552.2 ± 679.4 nmol/l, respectively), whereas that of lysophosphatidylcholine was lower, in PCOS women than in healthy controls (82.02 ± 39.49 vs. 133.62 ± 65.36 μmol/l, respectively). Receiver operating characteristic analysis showed that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) had the greatest discriminatory power to differentiate between women with and without PCOS (area under the curve: 0.889, 95% confidence interval: 0.784-0.994). These results indicate that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) may represent a novel lipid predictor of PCOS.This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed to analyze serum lipid profiles. Shotgun lipidomics revealed that the concentrations of ceramide (Cer) and phosphatidylcholine (PC) were higher (PC: 831.6 ± 217.4 vs. 605.2 ± 164.2 μmol/l; Cer: 3,387.6 ± 829.9 vs. 2,552.2 ± 679.4 nmol/l, respectively), whereas that of lysophosphatidylcholine was lower, in PCOS women than in healthy controls (82.02 ± 39.49 vs. 133.62 ± 65.36 μmol/l, respectively). Receiver operating characteristic analysis showed that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) had the greatest discriminatory power to differentiate between women with and without PCOS (area under the curve: 0.889, 95% confidence interval: 0.784-0.994). These results indicate that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) may represent a novel lipid predictor of PCOS.
This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen women with PCOS and 17 healthy controls were enrolled. A multi-dimensional mass spectrometry-based shotgun lipidomics approach was employed to analyze serum lipid profiles. Shotgun lipidomics revealed that the concentrations of ceramide (Cer) and phosphatidylcholine (PC) were higher (PC: 831.6 ± 217.4 . 605.2 ± 164.2 μmol/l; Cer: 3,387.6 ± 829.9 . 2,552.2 ± 679.4 nmol/l, respectively), whereas that of lysophosphatidylcholine was lower, in PCOS women than in healthy controls (82.02 ± 39.49 . 133.62 ± 65.36 μmol/l, respectively). Receiver operating characteristic analysis showed that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) had the greatest discriminatory power to differentiate between women with and without PCOS (area under the curve: 0.889, 95% confidence interval: 0.784-0.994). These results indicate that the combination of Cer (OH_N16:0/N18:0) and Cer (N22:0) may represent a novel lipid predictor of PCOS.
Author Jiang, Yihong
Li, Shengxian
Huang, Rong
Liu, Wei
Yin, Huiyong
Qi, Jia
Xue, Xinli
Zheng, Jun
Author_xml – sequence: 1
  givenname: Yihong
  surname: Jiang
  fullname: Jiang, Yihong
  organization: Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University
– sequence: 2
  givenname: Jia
  surname: Qi
  fullname: Qi, Jia
  organization: Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics
– sequence: 3
  givenname: Xinli
  surname: Xue
  fullname: Xue, Xinli
  organization: CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS)
– sequence: 4
  givenname: Rong
  surname: Huang
  fullname: Huang, Rong
  organization: Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University
– sequence: 5
  givenname: Jun
  surname: Zheng
  fullname: Zheng, Jun
  organization: Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University
– sequence: 6
  givenname: Wei
  surname: Liu
  fullname: Liu, Wei
  organization: Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University
– sequence: 7
  givenname: Huiyong
  surname: Yin
  fullname: Yin, Huiyong
  email: hyyin@sibs.ac.cn
  organization: Key Laboratory of Food Safety Risk Assessment, Ministry of Health
– sequence: 8
  givenname: Shengxian
  surname: Li
  fullname: Li, Shengxian
  email: rj_shengxianli@163.com
  organization: Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31793360$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9uFDEMxiNURLeFRwDlyGWW_NnNJHABrVpAqtRLOY8yidMGMsmQZLaa9-CBmdVuOXCAiy3Lv8-2_F2gs5giIPSakjUlkrwjakv5VpE1I1StqVCSMPEMreim5Q1phThDqwPTHKBzdFHKd0Io37TsBTrntFWcC7JCv3aQ9eAt4DL1JuhSoOCljNU7DxbrgmPaQ8DBj97i3qdB5x-QMQTY67oQPuLHNMASfX3AYwqzmUv1Bqe9zjMuc7R56b_HGo8-pIpLneyMYRhDmn28x-Uh1fspHjekwZvyEj13OhR4dcqX6Nv11d3uS3Nz-_nr7tNNY7gQtQGrmHNK97xXfON6sZXScS16pxknTDNBFLTSGSUFF7Kn0DKremqItFQayS_R2-PcMaefE5TaDb4YCEFHSFPpGGdEKsIkX9A3J3TqB7DdmP3yiLl7-uQCbI-AyamUDO4PQkl3cKx7cqw7ONadHFt0H_7SGV919SnWrH34r_rjUe2jS3nQjykH21U9h5Rd1tH4spz4zxG_AV3Wsm4
CitedBy_id crossref_primary_10_3389_fendo_2025_1546512
crossref_primary_10_3390_metabo11120869
crossref_primary_10_1016_j_cmet_2020_11_012
crossref_primary_10_1038_s41522_021_00231_6
crossref_primary_10_1111_ijpo_12734
crossref_primary_10_3389_fcell_2025_1575431
crossref_primary_10_3389_fendo_2022_960274
crossref_primary_10_3390_ijms21124501
crossref_primary_10_1007_s10815_023_02724_z
crossref_primary_10_3389_fcvm_2020_552421
crossref_primary_10_1016_j_cca_2025_120425
crossref_primary_10_3390_jcm12041500
crossref_primary_10_1016_j_cophys_2023_100717
crossref_primary_10_1186_s12882_025_04142_y
crossref_primary_10_1016_j_ando_2022_07_675
crossref_primary_10_1210_jendso_bvac131
crossref_primary_10_1038_s43856_025_00985_6
crossref_primary_10_1038_s42003_022_03710_4
crossref_primary_10_1080_10408363_2024_2430775
crossref_primary_10_3389_fendo_2023_1239276
Cites_doi 10.1007/BF00280883
10.1038/s41598-019-38944-6
10.1210/jc.2006-2725
10.1530/JME-17-0023
10.18632/oncotarget.23393
10.1210/er.2011-1034
10.1016/j.fertnstert.2008.09.070
10.2337/db12-0686
10.1021/pr3000317
10.1093/humupd/dmq001
10.1007/s00018-009-0106-3
10.1194/jlr.D500007-JLR200
10.1016/j.tibs.2007.09.004
10.1002/oby.21448
10.1161/CIRCGENETICS.114.000600
10.1016/j.ab.2004.04.004
10.1371/journal.pone.0074341
10.1038/nrendo.2018.24
10.1016/S0140-6736(07)61345-2
10.1007/s11306-014-0726-y
10.2337/db17-1449
10.1016/j.tem.2007.07.003
10.1186/1476-511X-12-98
10.1093/humrep/deh098
10.1016/j.metabol.2017.09.016
10.1242/jcs.02637
ContentType Journal Article
Copyright 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
Copyright_xml – notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/09513590.2019.1698026
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-0766
EndPage 512
ExternalDocumentID 31793360
10_1080_09513590_2019_1698026
1698026
Genre Article
Journal Article
Observational Study
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81471029; 81671518; 91857112; 31671231
– fundername: Chinese Ministry of Science and Technology (MOST)
  grantid: 2016YFD0400205
– fundername: Ministry of Science and Technology of the People's Republic of China
GroupedDBID ---
00X
03L
0YH
29I
36B
4.4
53G
5GY
AAGDL
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABWVI
ABXYU
ACENM
ACGEJ
ACGFO
ACGFS
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AEGXH
AENEX
AEOZL
AFKVX
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AHMBA
AIAGR
AIJEM
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
AQTUD
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LGLTD
LJTGL
M4Z
O9-
P2P
RNANH
RRB
RVRKI
RWL
SV3
TAE
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAYXX
CITATION
5VS
7X7
88E
8AO
8FI
8FJ
AAFWJ
AALIY
AAORF
AAPXX
ABUWG
ABWCV
ABZEW
ACKZS
ACOPL
ACYZI
ADBBV
ADFOM
ADFZZ
ADYSH
AEIIZ
AFKRA
AFLEI
AFPKN
AJVHN
ALIPV
AWYRJ
BENPR
BPHCQ
BRMBE
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
FYUFA
GROUPED_DOAJ
HMCUK
IPNFZ
JENTW
M1P
M44
NPM
NUSFT
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
QQXMO
RIG
S0X
UKHRP
7X8
ID FETCH-LOGICAL-c366t-ed92ff9ab3b934fb6588f3a6bfa2302a2609e78fc986368b1e72d9b1c08d18c83
IEDL.DBID TFW
ISICitedReferencesCount 25
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000500143000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0951-3590
1473-0766
IngestDate Thu Sep 04 19:56:21 EDT 2025
Mon Jul 21 06:05:29 EDT 2025
Sat Nov 29 01:36:38 EST 2025
Tue Nov 18 22:43:32 EST 2025
Mon Oct 20 23:48:38 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Polycystic ovary syndrome
ceramide
shotgun lipidomics
insulin resistance
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c366t-ed92ff9ab3b934fb6588f3a6bfa2302a2609e78fc986368b1e72d9b1c08d18c83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 31793360
PQID 2320890283
PQPubID 23479
PageCount 5
ParticipantIDs crossref_primary_10_1080_09513590_2019_1698026
pubmed_primary_31793360
informaworld_taylorfrancis_310_1080_09513590_2019_1698026
proquest_miscellaneous_2320890283
crossref_citationtrail_10_1080_09513590_2019_1698026
PublicationCentury 2000
PublicationDate 2020-06-02
PublicationDateYYYYMMDD 2020-06-02
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-02
  day: 02
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Gynecological endocrinology
PublicationTitleAlternate Gynecol Endocrinol
PublicationYear 2020
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0010
CIT0012
CIT0011
CIT0013
CIT0016
CIT0015
CIT0018
CIT0017
CIT0019
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Li S (CIT0014) 2017; 102
CIT0003
CIT0025
CIT0002
CIT0024
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0006
CIT0009
CIT0008
References_xml – ident: CIT0017
  doi: 10.1007/BF00280883
– ident: CIT0020
  doi: 10.1038/s41598-019-38944-6
– ident: CIT0008
  doi: 10.1210/jc.2006-2725
– ident: CIT0015
  doi: 10.1530/JME-17-0023
– ident: CIT0016
  doi: 10.18632/oncotarget.23393
– ident: CIT0004
  doi: 10.1210/er.2011-1034
– ident: CIT0007
  doi: 10.1016/j.fertnstert.2008.09.070
– ident: CIT0023
  doi: 10.2337/db12-0686
– ident: CIT0025
  doi: 10.1021/pr3000317
– ident: CIT0005
  doi: 10.1093/humupd/dmq001
– ident: CIT0027
  doi: 10.1007/s00018-009-0106-3
– ident: CIT0019
  doi: 10.1194/jlr.D500007-JLR200
– ident: CIT0021
  doi: 10.1016/j.tibs.2007.09.004
– ident: CIT0012
  doi: 10.1002/oby.21448
– ident: CIT0010
  doi: 10.1161/CIRCGENETICS.114.000600
– ident: CIT0018
  doi: 10.1016/j.ab.2004.04.004
– ident: CIT0011
  doi: 10.1371/journal.pone.0074341
– ident: CIT0001
  doi: 10.1038/nrendo.2018.24
– ident: CIT0003
  doi: 10.1016/S0140-6736(07)61345-2
– ident: CIT0013
  doi: 10.1007/s11306-014-0726-y
– ident: CIT0024
  doi: 10.2337/db17-1449
– ident: CIT0009
  doi: 10.1016/j.tem.2007.07.003
– ident: CIT0022
  doi: 10.1186/1476-511X-12-98
– ident: CIT0002
  doi: 10.1093/humrep/deh098
– ident: CIT0006
  doi: 10.1016/j.metabol.2017.09.016
– volume: 102
  start-page: 810
  issue: 3
  year: 2017
  ident: CIT0014
  publication-title: J Clin Endocrinol Metab
– ident: CIT0026
  doi: 10.1242/jcs.02637
SSID ssj0013472
Score 2.3620164
Snippet This study aimed to identify potential lipid biomarkers in women with polycystic ovary syndrome (PCOS) and determine their predictive value for PCOS. Eighteen...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 508
SubjectTerms Adolescent
Adult
Biomarkers - blood
Case-Control Studies
ceramide
Ceramides - blood
Ceramides - classification
China
Cross-Sectional Studies
Female
Humans
insulin resistance
Lipidomics - methods
Lipids - blood
Pilot Projects
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - diagnosis
Predictive Value of Tests
shotgun lipidomics
Up-Regulation
Young Adult
Title Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics
URI https://www.tandfonline.com/doi/abs/10.1080/09513590.2019.1698026
https://www.ncbi.nlm.nih.gov/pubmed/31793360
https://www.proquest.com/docview/2320890283
Volume 36
WOSCitedRecordID wos000500143000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAWR
  databaseName: Taylor & Francis Online Journals
  customDbUrl:
  eissn: 1473-0766
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013472
  issn: 0951-3590
  databaseCode: TFW
  dateStart: 19870101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQogLlPdCWw0S15Q4ziY2N1Sx4tKKQxF7i_yESGmyirMr7f_gB-NxkkIPVQ_wAyZOnLHnm9c3hLwPIIQqbpZJal2e5AGSJJw6miwRDOSWGmdNHDZRXlzw9Vp8naoJ_VRWiT60G4ki4l2Nh1sqP1fEfUBUwJYixcIscUoLwYMjEW7hYPpxhsHl6vufPEIexzfFYfIoMvfw3PaUG9bpBnfp7Qg0WqLVk__wDYfk8QRD4dOoN0_JPds-Iw_Pp0T7c_LrzPbyqjYW_FZpRNjWQ23G0iJrQHpou51toKk3tQFs4sc6nx6wXT3AVwN1C5HdATDSC5uu2es9ckJDt5P9HmamhI8gYVM33QCR6BZsnEAc7Cn4n93wY9uOK2DvtH9Bvq0-X559SaYBDolmRTEk1ojMOSEVU4LlTgW0wx2ThXIyeD6ZDL6UsCV3WvCCFVxRW2ZGKKpTbijXnL0kB23X2tcE0KxKpoJp5SqnWghdSGRWlRlXokz1guTzj6v0xG6OQzaais4kqNOOV7jj1bTjC3J6LbYZ6T3uEhB_a0U1xLiKG4egVOwO2XezClXhEGNmRra22_oqwNoUE76cLcirUbeuX4fhFcqK9M0_rPyWPMowToDRo-yIHAz91h6TB3o31L4_IffLNT-JB-c3JX8T0A
linkProvider Taylor & Francis
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIMqFd2Epj0HimhLH2azNraq6KqLd0yJ6i_wskUKySrIr7f_gB-NxktIeqh7oD5g4ccaeb17fEPLZgxCquJlGsXVplHpIEnHqaDRFMJBaapw1YdjEbLHg5-fiai8MllWiD-16oohwV-PhxmD0WBL3BWEBm4oYK7PEAc0E957EffJg6m0tavly_vNfJiENA5zCOHmUGbt4bnrMNft0jb30ZgwabNH86V18xTPyZECicNirznNyz1YvyKOzIdf-kvw5so38XRgL7VppBNm2hcL01UXWgGyhqje2hLJYFQawjx9LfRrAjnWPYA0UFQSCB8BgL6zqcqu3SAsN9UY2WxjJEr6ChFVR1h0ErluwYQixN6nQ_qq7i3XVr4Dt0-0r8mN-vDw6iYYZDpFmWdZF1ojEOSEVU4KlTnnAwx2TmXLSOz-J9O6UsDPutOAZy7iidpYYoaiOuaFcc7ZHdqq6sm8IoGWVTHnrylVKtRA6k0iuKhOuxCzWE5KOfy7XA8E5ztkoczryoA47nuOO58OOT8jBpdiqZ_i4TUBcVYu8C6EV189Bydktsp9GHcr9OcbkjKxsvW5zj2xjzPlyNiGve-W6fB2GtyjL4rf_sfJHsnuyPDvNT78tvu-TxwmGDTCYlLwjO12ztu_JQ73pirb5EM7PXxJpFxM
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagoIpLedOlBQaJa0ocZ7M2t6plBQJWPRTRW-QnRApJlGRX2v_BD8bjJIUeqh7gB0ycOGPPN69vCHnjQQhV3Myj2Lo0Sj0kiTh1NJojGEgtNc6aMGxisVrxiwtxNlYTdmNZJfrQbiCKCHc1Hu7GuKki7i2iAjYXMRZmiSOaCe4didvkjofOGfpf58tvfxIJaZjfFKbJo8zUxHPdY66YpyvkpddD0GCKlvf_w0c8IHsjDoXjQXEeklu2ekR2v4yZ9sfk14lt5c_CWOjWSiPEth0UZqgtsgZkB1W9sSWURVMYwC5-LPRpAfvVPX41UFQQ6B0AQ73Q1OVWb5EUGuqNbLcwUSW8AwlNUdY9BKZbsGEEsTeo0P2o--_ralgBm6e7J-Tr8v35yYdonOAQaZZlfWSNSJwTUjElWOqUhzvcMZkpJ73rk0jvTAm74E4LnrGMK2oXiRGK6pgbyjVnT8lOVVd2nwDaVcmUt61cpVQLoTOJ1Koy4UosYj0j6fTjcj3Sm-OUjTKnEwvquOM57ng-7viMHF2KNQO_x00C4m-tyPsQWHHDFJSc3SD7elKh3J9iTM3IytbrLve4NsaML2cz8mzQrcvXYXiHsix-_g8rvyK7Z6fL_PPH1acDci_BmAFGkpJDstO3a_uC3NWbvujal-H0_AaxcRXE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ceramide+subclasses+identified+as+novel+lipid+biomarker+elevated+in+women+with+polycystic+ovary+syndrome%3A+a+pilot+study+employing+shotgun+lipidomics&rft.jtitle=Gynecological+endocrinology&rft.au=Jiang%2C+Yihong&rft.au=Qi%2C+Jia&rft.au=Xue%2C+Xinli&rft.au=Huang%2C+Rong&rft.date=2020-06-02&rft.eissn=1473-0766&rft.volume=36&rft.issue=6&rft.spage=508&rft_id=info:doi/10.1080%2F09513590.2019.1698026&rft_id=info%3Apmid%2F31793360&rft.externalDocID=31793360
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-3590&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-3590&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-3590&client=summon